NCT00757445

Brief Summary

This study presents the investigators results on patients treated for infection in the implemented hip prosthesis. Debridement and prosthesis retention is the method, followed by antibiotic treatment. The investigators present treatment results, predisposing factors and microbiological data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 1997

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1997

Completed
10.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 22, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 23, 2008

Completed
Last Updated

September 23, 2008

Status Verified

September 1, 2008

Enrollment Period

10.9 years

First QC Date

September 22, 2008

Last Update Submit

September 22, 2008

Conditions

InfectionDebridement With Prosthesis Retention

Keywords

Antibiotic therapyMicrobiological diagnosis

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with prosthesis infection in hip

You may qualify if:

  • Infection in prothesis in hip treated with debridement and prosthesis retention

You may not qualify if:

  • Other technique

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sorlandet Hospital HF

Kristiansand, Agder, 4600, Norway

Location

MeSH Terms

Conditions

Infections

Study Officials

  • Bjoern Waagsboe, MD

    Sorlandet Hospital HF

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

September 22, 2008

First Posted

September 23, 2008

Study Start

January 1, 1997

Primary Completion

December 1, 2007

Study Completion

December 1, 2007

Last Updated

September 23, 2008

Record last verified: 2008-09

Locations

NO(1)